Navigation Links
Quercegen Pharmaceuticals LLC Obtains FDA GRAS Notified Status for its QU995™ Quercetin with Purity Greater than 99.5%
Date:2/3/2011

SUDBURY, Mass., Feb. 3, 2011 /PRNewswire/ -- Quercegen Pharmaceuticals LLC, producer of plant-based nutrients for the pharmaceutical and nutraceutical industries and creator of Q-Force™, was notified that its QU995™, The World's Purest Quercetin™, received GRAS ("Generally Recognized As Safe") notified status on November 22, 2010 under U.S. Food and Drug Administration GRAS Inventory Number GRN 341. A copy of the comprehensive safety dossier submitted to the FDA by Quercegen can be found on the Agency's website. www.fda.gov/Food/FoodIngredientsPackaging/GenerallyRecognizedasSafeGRAS/GRASListings/ucm235935.htm

(Logo: http://photos.prnewswire.com/prnh/20110203/NE42268LOGO)

Quercetin is a natural polyphenolic antioxidant flavonoid found in many plants. It plays an important role in the inhibition of enzymes involved in free radical production and can potentially be used for the prevention and alleviation of conditions that cause oxidative stress. Quercetin is being studied for a wide range of health and performance benefits across the globe and is now serving as a functional ingredient to foods, beverages and dietary supplements.

"Achieving GRAS Status represents a major milestone for Quercegen Pharmaceuticals," said Quercegen CEO Gordon Brooks. "After many years of hard work and significant investment we are delighted to be able to offer products with our highly purified, food-grade Quercetin at levels of up to 500 milligrams per serving. We are grateful to our relentless science team as well as our commercial partners who helped us to achieve this."

Evolving from self-affirmed GRAS to gaining GRAS notified status from the FDA expands opportunities for QU995™ Quercetin to no longer be limited to dietary supplements, but can be used by food manufacturers worldwide. To be accepted in the mass food
'/>"/>

SOURCE Quercegen Pharmaceuticals LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... , July 6, 2015   BioClinica®, Inc ... provider, today announced that it has acquired a ... ® , Inc. (Medici).  The acquisition includes affiliates ... LLC.  Medici also provides a lost-to-follow-up patient locate ... globally.  Together with Medici, BioClinica will ...
(Date:7/6/2015)... BEDFORD, Mass. , July 6, 2015 ... the Company plans to release its financial results for ... 29, 2015, after the market closes.  In conjunction with ... day at 4:30 p.m. Eastern Time. Interested ... (in the United States ) or ...
(Date:7/6/2015)... FARMINGTON, Conn. , July 6, ... a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics ... medical need and commercial potential, today announced that ... Series E warrants to purchase 21,917,808 shares of ... purchase 2,191,781 shares of its common stock.  Certain ...
Breaking Medicine Technology:BioClinica Acquires MediciGroup 2BioClinica Acquires MediciGroup 3Hologic to Announce Financial Results for the Third Quarter of Fiscal 2015 on Wednesday, July 29, 2015 2Palatin Technologies Completes $30 Million Financing 2Palatin Technologies Completes $30 Million Financing 3Palatin Technologies Completes $30 Million Financing 4Palatin Technologies Completes $30 Million Financing 5
... 29, 2012 STAAR Surgical Company (NASDAQ: ... implantable lenses for the eye, today announced that it ... the Company,s recent financial results and current business developments ... Company One-on-One Investor Conference will be held on Thursday, ...
... May 29, 2012  Abaxis, Inc. (NasdaqGS: ABAX), a medical ... that Clint Severson, chairman and chief executive officer , ... on Tuesday, June 5, 2012 at 9:00 a.m. ET. ... in New York City. About AbaxisAbaxis ...
Cached Medicine Technology:STAAR Surgical To Present At The Benchmark And Jefferies Investor Conferences 2
(Date:7/6/2015)... ... July 06, 2015 , ... ... for radiology services and ADVOCATE is leading the transition. ADVOCATE, the only 100% ... with their Top 10 Tips for ICD-10. The ten tips are timely and ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... ... redesigned site allows newly-diagnosed cancer patients, caregivers and medical professionals to chat with ... survived the same cancer. , “Receiving a cancer diagnosis is often the most ...
(Date:7/6/2015)... ... July 06, 2015 , ... With ... has once again teamed up with Family Emergency Shelter Coalition (FESCO) and announced ... self-sufficiency. FESCO was created especially to provide emergency services and support for homeless ...
(Date:7/6/2015)... ... July 06, 2015 , ... With a new community ... with Livonia Save Our Youth and announced a new charity campaign to raise funds ... to alcohol and drug abuse. Livonia Save Our Youth is a coalition created especially ...
(Date:7/6/2015)... ... July 06, 2015 , ... Dr. Lawrence Green is now offering ... Kybella is a non-surgical method to dissolve fat cells and is the ... severe fat deposits under the chin, commonly known as a double chin. Dr. Green ...
Breaking Medicine News(10 mins):Health News:ADVOCATE Takes the Lead to Ensure ICD-10 Success: “Top 10 Tips for ICD-10” 2Health News:Cancer Hope Network Launches Upgraded Website to Support Cancer Patients, Caregivers 2Health News:Carlson & Associates Insurance Agency and Nonprofit Family Emergency Shelter Coalition (FESCO) Initiate New Charity Campaign in Alameda County, CA to Provide for Homeless 2Health News:Carlson & Associates Insurance Agency and Nonprofit Family Emergency Shelter Coalition (FESCO) Initiate New Charity Campaign in Alameda County, CA to Provide for Homeless 3Health News:Bowker Insurance Group and Nonprofit Livonia Save Our Youth Initiate New Charity Campaign in Livonia, MI to Provide for The Health and Safety of The Communities’ Youth 2Health News:Bowker Insurance Group and Nonprofit Livonia Save Our Youth Initiate New Charity Campaign in Livonia, MI to Provide for The Health and Safety of The Communities’ Youth 3Health News:Rockville, MD Practice Now Offering New FDA-Approved Non-Surgical Double Chin Treatment 2
... 8, 2008 Optimal Readings,Services Group, Inc., a ... radiology groups, announced today that Rita Edwards has,been ... the recent acquisition of two radiology groups (National,Radiology ... provides,radiology services for more than 115 hospitals," said ...
... lung cancer (SCLC) patients treated with high-dose chemotherapy did ... standard doses, according to a randomized controlled trial published ... National Cancer Institute . , SCLC accounts for nearly ... States. Although many patients with SCLC initially respond to ...
... ports and shipping regions may be markedly worse than ... industrial and shipping pollution is exacerbated when it combines ... paper published in this weeks advance online edition of ... included University of Calgary chemistry professor Hans Osthoff report ...
... DUBLIN, Ohio, April 8, 2008 Cardinal Health,Inc. (NYSE: ... that improve,the safety and productivity of health care, plans to ... to the opening of trading,on the New York Stock Exchange., ... for May 1 at,8:30 a.m. EDT to discuss results of ...
... Survival time rose with combo therapy for advanced disease, ... By combining a special type of chemotherapy (TACE) with ... the survival of people with advanced liver cancer by ... either treatment alone. , "Our study demonstrates that combination ...
... drugs by women during their childbearing years and there ... alone or in combination with other drugs, may have ... evidence that THC, the main psychoactive component of marijuana, ... intrauterine growth retardation and that infants exposed to marijuana ...
Cached Medicine News:Health News:Optimal Readings Appoints Operations Veteran Rita Edwards as SVP Clinical Operations 2Health News:High-intensity chemotherapy does not improve survival in small cell lung cancer 2Health News:Sea salt worsens coastal air pollution: study 2Health News:Cardinal Health to Announce Third-Quarter Results on May 1 2Health News:Cardinal Health to Announce Third-Quarter Results on May 1 3Health News:Two Liver Cancer Treatments Better Than One 2Health News:Two Liver Cancer Treatments Better Than One 3Health News:Marijuana increases alcohol toxicity in young rats 2
... ACMI™ offers five classes of ... vaporization, cutting loops, knife, roller bar ... are the only electrodes specifically integrated ... surgical tissue removal with minimal bleeding, ...
... ACMITM MRO™-2004 and MRO™-2005 Rigid ... and large working throughput capacity with ... large operating channels with small size ... irrigation ports for easy positioning during ...
... Rotating Continuous Flow Resectoscopes enhance ease of ... the working element and telescope to the ... result no rotating components in the ... rotating flow ports, simplifying procedures. The new ...
... Used for temporary internal drainage from the ... material is engineered for ease of placement ... monofilament tether designed for repositioning and ease ... of hydrophilic polymer that when activated, attracts ...
Medicine Products: